Assignee
IRR INC
US·4 granted patents·6 pending applications·6 citations·filing 2018–2024
Top patents by PatentIndex Score
10 records- 0187US10792281B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsIRR INC·Filed 2018·Granted Oct 6, 2020·3 cites·16 claims
- 0286US11344545B2Use of levocetirizine and montelukast in the treatment of autoimmune disordersIRR INC·Filed 2018·Granted May 31, 2022·2 cites·22 claims
- 0383US11590125B2Levocetirizine and montelukast in the treatment of inflammation mediated conditionsIRR INC·Filed 2020·Granted Feb 28, 2023·1 cites·11 claims
- 0475US2025090522A1Levocetirizine and montelukast in the treatment of coronavirus disease and symptoms thereofIRR INC·Filed 2024·Application pending·0 cites
- 0569US2023190734A1Levocetirizine and montelukast in the treatment of coronavirus disease and symptoms thereofIRR INC·Filed 2022·Application pending·0 cites
- 0668US2020101067A1Use of levocetirizine and montelukast in the treatment of anaphylaxisIRR INC·Filed 2019·Application pending·0 cites
- 0767US2020323843A1Use of levocetirizine and montelukast in the treatment of viral infection caused by coronavirusIRR INC·Filed 2020·Application pending·0 cites
- 0863US12514855B2Levocetirizine and montelukast in the treatment of sepsis and symptoms thereofIRR INC·Filed 2021·Granted Jan 6, 2026·0 cites·15 claims
- 0963US2019298714A1Use of levocetirizine and montelukast to treat rhinosinusitis and nasal polyposisIRR INC·Filed 2019·Application pending·0 cites
- 1048US2019091218A1Levocetirizine and montelukast in the treatment of radiation-mediated conditionsIRR INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IRR INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →